Cargando…
Failure to confirm a sodium–glucose cotransporter 2 inhibitor‐induced hematopoietic effect in non‐diabetic rats with renal anemia
AIMS/INTRODUCTION: Clinical studies have shown that treatment with inhibitors of sodium–glucose cotransporter 2 (SGLT2) significantly increases the hematocrit in patients with type 2 diabetes. To investigate whether SGLT2 inhibitors directly promote erythropoietin production independently on blood g...
Autores principales: | Yamazaki, Daisuke, Konishi, Yoshio, Morikawa, Takashi, Kobara, Hideki, Masaki, Tsutomu, Hitomi, Hirofumhi, Osafune, Kenji, Nakano, Daisuke, Kittikulsuth, Wararat, Nishiyama, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378420/ https://www.ncbi.nlm.nih.gov/pubmed/31880858 http://dx.doi.org/10.1111/jdi.13205 |
Ejemplares similares
-
Responses of renal hemodynamics and tubular functions to acute sodium–glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats
por: Ansary, Tuba M., et al.
Publicado: (2017) -
Effect of a SGLT2 inhibitor on the systemic and intrarenal renin–angiotensin system in subtotally nephrectomized rats
por: Li, Lei, et al.
Publicado: (2017) -
Luseogliflozin, a SGLT2 Inhibitor, Does Not Affect Glucose Uptake Kinetics in Renal Proximal Tubules of Live Mice
por: Zhang, Anqi, et al.
Publicado: (2021) -
Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice
por: Kittikulsuth, Wararat, et al.
Publicado: (2023) -
A novel approach to adenine-induced chronic kidney disease associated anemia in rodents
por: Rahman, Asadur, et al.
Publicado: (2018)